Long-term safety and tolerability of once-monthly aripiprazole intramuscular depot for maintenance treatment in schizophrenia

被引：0
|
作者：
Baker, R. [1 ]
Fleischhacker, W.
Sanchez, R.
Perry, P. [1 ]
Jin, N.
Johnson, B.
Forbes, R. A.
McQuade, R. D.
Carson, W. H.
Kane, J. M.
机构：
[1] Otsuka Pharma, Princeton, NJ USA
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2012年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-08-003
引用
收藏
页码：111 / 111
页数：1
相关论文
共 50 条
  • [1] Long-term safety and tolerability of aripiprazole once-monthly in maintenance treatment of patients with schizophrenia
    Fleischhacker, W. Wolfgang
    Sanchez, Raymond
    Johnson, Brian
    Jin, Na
    Forbes, Robert A.
    McQuade, Robert
    Baker, Ross A.
    Carson, William
    Kane, John M.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2013, 28 (04) : 171 - 176
  • [2] A PLACEBO-CONTROLLED STUDY OF EFFICACY AND SAFETY OF ARIPIPRAZOLE ONCE-MONTHLY FOR LONG-TERM MAINTENANCE TREATMENT IN SCHIZOPHRENIA
    Eramo, A.
    Fleischhacker, W. W.
    Sanchez, R.
    Perry, P.
    Jin, N.
    Johnson, B.
    McQuade, R. D.
    Carson, W. H.
    Kane, J.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [3] Adherence, Tolerability and Effective Doses of Aripiprazole Once-monthly in the Long-term Treatment of Patients with Severe Schizophrenia
    Fernandez-Miranda, Juan J.
    Diaz-Fernandez, Silvia
    Lopez-Munoz, Francisco
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (39) : 4078 - 4085
  • [4] Adherence, tolerability and effective doses of aripiprazole once-monthly in the long-term treatment of patients with severe schizophrenia
    Fernandez-Miranda, J. J.
    Diaz-Fernandez, S.
    Lopez-Munoz, F.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S339 - S339
  • [5] Aripiprazole once-monthly for long-term maintenance treatment of schizophrenia: a 52-week open-label study
    Peters-Strickland, T.
    Baker, R. A.
    McQuade, R.
    Jin, N.
    Eramo, A.
    Perry, P.
    Johnson, B.
    Duca, A.
    Sanchez, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S542 - S542
  • [6] Aripiprazole once-monthly for long-term maintenance treatment of schizophrenia: A 52-week open-label study
    Baker, R.
    Peters-Strickland, T.
    McQuade, R. D.
    Jin, N.
    Eramo, A.
    Perry, P. P.
    Johnson, B. R.
    Duca, A. R.
    Sanchez, R.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 64 - 64
  • [7] A placebo-controlled study of efficacy/safety of aripiprazole intramuscular depot for long-term maintenance treatment of schizophrenia
    Sanchez, R.
    Perry, P.
    Jin, N.
    Johnson, B.
    Forbes, R. A.
    McQuade, R. D.
    Carson, W. H.
    Fleischhacker, W.
    Kane, J. M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S327 - S327
  • [8] PSYCHOSOCIAL AND OVERALL EFFECTIVENESS OF ARIPIPRAZOLE ONCE-MONTHLY VS. PLACEBO ONCE-MONTHLY FOR MAINTENANCE TREATMENT IN SCHIZOPHRENIA
    Baker, R.
    Carson, W. H.
    Perry, P.
    Sanchez, R.
    Jin, N.
    McQuade, R. D.
    Kane, J.
    Fleischhacker, W. W.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [9] Schizophrenia relapse and the clinical usefulness of once-monthly aripiprazole depot injection
    Wang, Sheng-Min
    Han, Changsu
    Lee, Soo-Jung
    Patkar, Ashwin A.
    Masand, Prakash S.
    Pae, Chi-Un
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2014, 10 : 1605 - 1611
  • [10] Aripiprazole once-monthly long-acting injectable for the treatment of schizophrenia
    Potkin, Steven G.
    Preda, Adrian
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (03) : 395 - 407
12345